Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 June, 2017 07:28 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Piramal Enterprises gets nod to raise up to Rs 1.25 bn - 23-Jun-2017 16:00
Bajaj Finance raises Rs 6 bn through issue of NCDs - 23-Jun-2017 11:04
ABAN Offshore arm bags order from Brunei Shell Petro for 5 years - 23-Jun-2017 10:47
Wockhardt settles ongoing commercial litigation with Teva - 23-Jun-2017 10:34
EID Parry's division forges partnership with Synthite Ind - 23-Jun-2017 10:28
Shriram EPC secures multiple orders worth Rs 1.65 bn - 23-Jun-2017 09:41
Wipro collaborates with Red Hat for cloud application factory - 23-Jun-2017 09:20
Reliance Defence to partner with Daher for aerospace components - 23-Jun-2017 09:16
Strides Shasun, Vivimed Labs achieve closure to set up JV in India, Singapore - 22-Jun-2017 14:26
PI Industries enters into JV agreement with Kumiai Chemical - 22-Jun-2017 14:22
Lupin launches generic Topicort LP Emollient Cream, Topicort cream in US - 22-Jun-2017 14:17
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer